1-215741541-GAA-GA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_206933.4(USH2A):​c.11549-5delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0163 in 1,117,120 control chromosomes in the GnomAD database, including 134 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 20 hom., cov: 32)
Exomes 𝑓: 0.017 ( 114 hom. )

Consequence

USH2A
NM_206933.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.396

Publications

4 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 39
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-215741541-GA-G is Benign according to our data. Variant chr1-215741541-GA-G is described in ClinVar as Benign. ClinVar VariationId is 177774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0102 (1414/138782) while in subpopulation AMR AF = 0.0416 (580/13952). AF 95% confidence interval is 0.0388. There are 20 homozygotes in GnomAd4. There are 737 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.11549-5delT splice_region_variant, intron_variant Intron 59 of 71 ENST00000307340.8 NP_996816.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.11549-5delT splice_region_variant, intron_variant Intron 59 of 71 1 NM_206933.4 ENSP00000305941.3
USH2AENST00000674083.1 linkc.11549-5delT splice_region_variant, intron_variant Intron 59 of 72 ENSP00000501296.1

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1405
AN:
138720
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0411
Gnomad ASJ
AF:
0.000304
Gnomad EAS
AF:
0.0239
Gnomad SAS
AF:
0.0281
Gnomad FIN
AF:
0.000775
Gnomad MID
AF:
0.0103
Gnomad NFE
AF:
0.00212
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.0520
AC:
6144
AN:
118084
AF XY:
0.0486
show subpopulations
Gnomad AFR exome
AF:
0.0225
Gnomad AMR exome
AF:
0.181
Gnomad ASJ exome
AF:
0.0415
Gnomad EAS exome
AF:
0.0674
Gnomad FIN exome
AF:
0.0213
Gnomad NFE exome
AF:
0.0189
Gnomad OTH exome
AF:
0.0613
GnomAD4 exome
AF:
0.0171
AC:
16767
AN:
978338
Hom.:
114
Cov.:
33
AF XY:
0.0176
AC XY:
8548
AN XY:
485518
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0254
AC:
551
AN:
21704
American (AMR)
AF:
0.120
AC:
3540
AN:
29458
Ashkenazi Jewish (ASJ)
AF:
0.0171
AC:
273
AN:
15984
East Asian (EAS)
AF:
0.0388
AC:
1002
AN:
25812
South Asian (SAS)
AF:
0.0464
AC:
2553
AN:
55048
European-Finnish (FIN)
AF:
0.0172
AC:
588
AN:
34236
Middle Eastern (MID)
AF:
0.0204
AC:
87
AN:
4262
European-Non Finnish (NFE)
AF:
0.00966
AC:
7267
AN:
752256
Other (OTH)
AF:
0.0229
AC:
906
AN:
39578
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.359
Heterozygous variant carriers
0
1483
2966
4449
5932
7415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1414
AN:
138782
Hom.:
20
Cov.:
32
AF XY:
0.0110
AC XY:
737
AN XY:
66892
show subpopulations
African (AFR)
AF:
0.0109
AC:
413
AN:
37900
American (AMR)
AF:
0.0416
AC:
580
AN:
13952
Ashkenazi Jewish (ASJ)
AF:
0.000304
AC:
1
AN:
3286
East Asian (EAS)
AF:
0.0236
AC:
113
AN:
4784
South Asian (SAS)
AF:
0.0284
AC:
126
AN:
4440
European-Finnish (FIN)
AF:
0.000775
AC:
6
AN:
7746
Middle Eastern (MID)
AF:
0.0113
AC:
3
AN:
266
European-Non Finnish (NFE)
AF:
0.00212
AC:
135
AN:
63664
Other (OTH)
AF:
0.0195
AC:
37
AN:
1900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0247
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 01, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

11549-5delT in intron 59 of USH2A: This variant is not expected to have clinica l significance because it has been identified in 2.0% (166/8241) of European Am erican chromosomes by the NHLBI Exome Sequencing Project, it occurs within a pol y-T tract, and is not predicted to impact splicing (http://evs.gs.washington.edu /EVS/; dbSNP rs34565443).

Aug 29, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Aug 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31054281)

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 2A Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinitis pigmentosa 39 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.40
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34565443; hg19: chr1-215914883; COSMIC: COSV56377184; API